bioRxiv/medRxiv TRiP Review Activity

78 Reviews — EMBO Press — Cancer Biology

Most recent first Previous |  Page 3: Articles 21-30  | Next

RAS and PP2A activities converge on epigenetic gene regulation
Aakula, A., Sharma, M., Tabaro, F., Honkanen, H., Schapira, M., Arrowsmith, C., Nykter, M., Westermarck, J.
10.1101/2022.05.11.491459 — Posted: 2022-05-12 — Discussion: 2023-05-26  EMBO Press
ROR1 plays a critical role in pancreatic tumor-initiating cells with a partial EMT signature.
Yamazaki, M., Hino, S., Usuki, S., Miyazaki, Y., Oda, T., Nakao, M., Ito, T., Yamagata, K.
10.1101/2022.07.13.499868 — Posted: 2022-07-14 — Discussion: 2023-05-19  EMBO Press
β-catenin activity induces an RNA biosynthesis program promoting therapy resistance in T Acute Lymphoblastic Leukemia
Garcia-Hernandez, V., Arambilet, D., Guillen, Y., Lobo, T., Gekas, C., Vega-Garcia, N., Sentis, I., Trincado, J. L., Marquez-Lopez, I., Heyn, H., Camos, M., Espinosa, L., Bigas, A.
10.1101/2022.07.07.499249 — Posted: 2022-07-09 — Discussion: 2023-04-27  EMBO Press
An RNA-binding switch drives ribosome biogenesis and tumorigenesis downstream of RAS oncogene
Azman, M. S., Dodel, M., Capraro, F., Faraway, R., Dermit, M., Fan, W., Ule, J., Mardakheh, F. K.
10.1101/2021.12.16.472890 — Posted: 2021-12-16 — Discussion: 2023-04-25  EMBO Press
Uveal Melanoma: a miR-16 disease?
Quemener, A. M., Bachelot, L., Aubry, M., Avner, S., Leclerc, D., Salbert, G., Cabillic, F., Decaudin, D., Mari, B., Mouriaux, F., Galibert, M.-D., Gilot, D.
10.1101/2021.11.30.470499 — Posted: 2021-12-01 — Discussion: 2023-03-15  EMBO Press
Blockade of pro-fibrotic response mediated by the miR-143/-145 cluster prevents targeted therapy-induced phenotypic plasticity and resistance in melanoma
Diazzi, S., Baeri, A., Fassy, J., Lecacheur, M., Marin-Bejar, O., Girard, C., Lefevre, L., Lacoux, C., Irondelle, M., Mounier, C., Truchi, M., Couralet, M., Carminati, A., Berestjuk, I., Larbret, F., Vassaux, G., Marine, J.-C., Deckert, M., Mari, B., Tartare-Deckert, S.
10.1101/2021.07.02.450838 — Posted: 2021-07-03 — Discussion: 2023-03-15  EMBO Press
The eukaryotic translation initiation factor eIF4E reprogrammes the splicing machinery anddrives alternative splicing
Ghram, M., Morris, G., Culjkovic-Kraljacic, B., Gendron, P., Skrabanek, L., Revuelta, M. V., Cerchietti, L., Guzman, M., Borden, K.
10.1101/2021.12.07.471666 — Posted: 2021-12-09 — Discussion: 2023-03-15  EMBO Press
The mechanosensitive TRPV2 calcium channel controls melanoma invasiveness and metastatic potential.
Shoji, K. F., Bayet, E., Le Devedec, D., Mallavialle, A., Marionneau-lambot, S., Leverrier-Penna, S., Rambow, F., Perret, R., Joussaume, A., Viel, R., Fautrel, A., Khammari, A., Constantin, B., Tartare-Deckert, S., Penna, A.
10.1101/2021.10.22.465391 — Posted: 2021-10-24 — Discussion: 2023-02-28  EMBO Press
TSC2 regulates tumor susceptibility to TRAIL-mediated T cell killing by orchestrating mTOR signaling
Peeper, D. S., Lin, C.-P., Traets, J. J. H., Vredevoogd, D. W., Visser, N. L.
10.1101/2022.05.09.491124 — Posted: 2022-05-10 — Discussion: 2023-02-15  EMBO Press
Pan-Cancer landscape of protein activities identifies drivers of signalling dysregulation and patient survival
Sousa, A., Dugourd, A., Memon, D., Petursson, B., Petsalaki, E., Saez-Rodriguez, J., Beltrao, P.
10.1101/2021.06.09.447741 — Posted: 2021-06-09 — Discussion: 2023-01-28  EMBO Press

Evaluation Sources